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Abstract
The high accumulation of lipid droplets in the cell is related to metabolic disorders, such as obesity. Perilipin 5 (Plin5), plays
an important role in triglyceride hydrolysis in the lipid droplets. In this study, this protein has been evaluated in different
tissues and conditions in mice. Fifty male mice were divided into 5 groups and treated for 45 days with Resveratrol,
Metformin, strength training, and 4 °C cold. Brown adipose tissue (BAT), gastrocnemius skeletal muscle and heart were
isolated for RNA extraction. The Plin5 gene expression was evaluated, using Real-Time PCR, and the plin5 was analyzed at
the protein level, using western blot. In BAT, Resveratrol signiﬁcantly reduced the plin5 protein level and gene expression
(p < 0.05). In heart tissue, Resveratrol and strength training, decreased (p < 0.05) the plin5 expression, but Metformin
increased the gene expression (p < 0.05). In skeletal muscle, resveratrol, strength training, cold and Metformin signiﬁcantly
increased the plin5 expression at the gene and protein level (p < 0.05). In BAT, Resveratrol has a greater effect in decreasing
lipid deposits, compared with the strength training and cold; thus, it can play a better role in preventing lipid accumulation.
In heart tissue, Resveratrol probably decreases insulin resistance, due to the increased expression of plin5 in skeletal muscle.
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Introduction
Obesity is identiﬁed as the greatest health problem world-
wide, with an increase in lipid accumulation in body tissues,
and is characterized by a BMI > 30 [1, 2]. Lipid droplets
(LD) play an important role in the metabolism and energy
balance in mammalian cells. There are more than two
hundred types of proteins in LD, most of which are perili-
pins (plins), playing an important role in stabilizing,
degenerating and transferring of LD. The high accumulation
of LD in the cell is related to metabolic disorders, such as
obesity, diabetes, and atherosclerosis [3, 4].
Plin5 or OX/PAT is more involved in tissues, such as the
heart, skeletal muscle, and brown adipose tissue (BAT),
taking part in the oxidation of fatty acid. This protein acts
around LD as scaffolds, and plays an important role in
lipolysis. Plin5 serves as a barrier by decreasing lipolysis
via PPARα, especially in the heart tissue, [5] and plays a
unique role in utilizing fatty acids’ oxidation, via PGC1α [6,
7]. In addition, it plays a signiﬁcant role in skeletal muscle
in lipolysis of fat droplets, and any impairment in its
function results in insulin resistance in skeletal muscle,
leading to ceramide accumulation [8].
Resveratrol is a polyphenol composition that exists in red
grape, peanut, berry, and other herbal compounds, having
anti-inﬂammatory and anti-oxidant effects and improving
glucose tolerance [9, 10]. Resveratrol also increases lipo-
lysis, decreases the synthesis of fatty acids and increases
fatty acid esteriﬁcation in mitochondria [11]. Furthermore,
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Resveratrol prevents the differentiation of progenitor lipid
cells (3T3-L1), into adult fat cells by reducing PPA R-γ
[12].
Cold causes an increase in PGC1α that is regulated and
controlled by PPARɣ and plin5 [13]. Metformin reduces the
activity of acetyl-coA carboxylase and increases oxidation
via AMPK in the liver cells [14].
Increasing the size and number of LD causes’ obesity,
increases insulin resistance and cardiovascular problems;
plins family, especially plin5, plays an important role in
controlling and regulating hydrolysis of LD, especially in
the cardiac tissue and oxidative tissues, such as BAT and
skeletal muscle. Therefore, this study aimed to examine the
effects of Resveratrol, Metformin, and cold and strength
training on the plin5 (mouse) expression in the indicated
tissues, in order to pave the path for controlling obesity and
its side effects.
Materials and Methods
Animals: In this experimental study, ﬁfty C57BL/6 J male
mice, 6–8 weeks-old, weighing 20–25 grams, were ran-
domly divided into ﬁve groups. The study was performed,
in accordance with the standard animal study guideline, and
all experimental protocols were approved by the Shahre-
Kord University of Medical Sciences Ethics Committee (IR.
SKUMS.REC.1395.195). For 45 days, the ﬁrst group
received DMSO, the second group 400 mg/kg of Resvera-
trol dissolved in DMSO, and the third group received
Metformin 250 mg/kg, via gavage. The fourth group per-
formed high-intensity strength training, using a treadmill
[15]. The ﬁfth group was initially kept at 18 °C for a week,
and then kept at 4 °C, until the end of the experiment
(45 days). After 45 days the mice were anesthetized with
chloroform and then the subclavicular BAT, gastrocnemius
muscle, and heart were isolated from the mice. RNA
extraction was performed, using Trizol (Ambion TRIZOL
reagent) and the quality and purity were investigated with a
Nanodrop (Thermo scientiﬁc 2000 spectrophotometer,
USA). DNase was used to remove potential DNA in the
reaction and then cDNA were synthesized, using the com-
mercial kit. RNA extraction and cDNA synthesis were
performed on ice bath. The plin5 gene expression was
measured with the Rotor-Gene Q 3000 (Australia), against
18 s RNA gene, using commercial kits, containing SYBR
green (Fermentas Thermo Scientiﬁc, Canada). The primer
sequences used in this study are presented in Table 1.
The ampliﬁcation was carried out, using the following
conditions: initial enzyme activation at 94 °C for 5 min, then
40 cycles of 95 °C for 15 s, 61.5 °C for 20 s, and 72 °C for
30 s. The quantitation of the data was performed, using the
comparative CT (2−ΔΔCT) method.
For western blots, ﬁrst BAT, gastrocnemius muscle and
heart were homogenized in RIPA Lysis buffer, containing
50 mM Tris Hcl, 150 Mm NaCl, 1%TritonX-100, 1Mm
EDTA, and 0.1% SDS 1 mM and then protein concentra-
tions were determined by the Bradford method [16].
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was
used as a reference protein.
Proteins were separated on 12% SDS PAGE, transferred
to a PVDF membrane, incubated with blocking buffer,
containing 5% Bovine Serum Albumin (BSA), and then
washed and incubated with primary antibody (anti-Perilipin
5 (C-terminus) guinea pig polyclonal antibody), (GP31,
Progen biotechnik, Heidelberg, Germany), as indicated
overnight at 4 °C. Subsequently, the membrane was washed
and incubated with rabbit anti-guinea pig polyclonal sec-
ondary antibody HRP (IgG H&L) (ab6771, Abcam, Cam-
bridge, UK) at room temperature for 2 h, and then the
protein band was visualized, using the ECL kit, and scanned
on a LICOR Biotechnology system.
Statistical analysis
Statistical analyses were performed, using non-parametric
Kruskal–Wallis test, and the pair comparisons between the
groups were performed by Mann–Whitney test. All statis-
tical analyses were performed, using Graph Pad Prism
software (v 6.01), and data were presented as mean ± SD.
All experiments were performed in triplicate and p < 0.05
was considered signiﬁcant.
Results
At the end of the study, the weight gain of the Metformin,
strength training, and cold groups was lower than the con-
trol group (p= 0.01, 0.03, 0.03, respectively), but no sig-
niﬁcant change has been found in the Resveratrol receiving
group, compared to the control group (p= 0.08).
In BAT, the plin5 expression was signiﬁcantly decreased
by 3.2 fold, compared to the control group, using Resver-
atrol (p= 0.02). The plin5 expression in the Metformin and
strength training groups increased by 2.3 and 1.8 fold,
respectively, compared to the control (Fig. 1a). The plin5
protein level also signiﬁcantly decreased by 2.43 fold, in
Table 1 Primer sequences and product lengths
Genes Primer Sequences (5′→ 3′) Amplicon
Length (bp)
Plin5 F: GGTGACATCAGCCAAGGATACAG
R: TCCACCAGCTTCTCCGACTT
147
18s RNA F: CGCAAATTACCCACTCCCGAC
R: GTAACCTCCCGTTCAGACCAC
133
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Resveratrol receiving group (p= 0.03), but no signiﬁcant
change has been found in Metformin, strength training, and
cold groups, compared to the control group (p= 0.19, 0.3,
0.2, respectively) (Fig. 1b).
In skeletal muscle, the plin5 expression increased by 3.21
(p= 0.005), 2.69 (p= 0.03), 4.08 (p= 0.002), and 2.5 fold
(p= 0.05), using Resveratrol, Metformin, strength training,
and cold, respectively, compared to the control group (Fig.
2a). The plin5 protein level, (showed in Fig. 2b) increased
in four treatment groups versus the control group (Resver-
atrol, 3.94 fold (p= 0.0018), Met (metformin), 2.45 fold (p
= 0.02), train (Strength training), 5.09 fold (p= 0.002), and
cold, 2.35 fold (p= 0.046).
In heart tissue, the plin5 expression was signiﬁcantly
decreased, by 1.89 fold (p= 0.046), and 5.3 fold (p=
0.005) by Resveratrol and strength training, respectively,
but Metformin slightly increased the gene expression level
by 1.84 fold, compared to the control group (p= 0.048).
The plin5 expression did not signiﬁcantly change, in cold-
treated group (1.46 fold, p= 0.3) (Fig. 3a).
In heart tissue, the plin5 protein level (Fig. 3b) was
decreased by 1.71 and 2.9 fold (p= 0.02, p= 0.01), in
Resveratrol and strength training groups, respectively,
compared to the control. No signiﬁcant change has been
found in protein content in heart tissue, after treatment with
Metformin and cold, compared to the control group (p=
0.08 and p= 0.3, respectively).
Fig. 1 The effects of Res
(Resveratrol) 400 mg/kg/day,
Met (Metformin)/250 mg/kg,
Cold and Train (Strength
training) on the plin5 expression
and Perilipin 5 protein content in
BAT. a Real-time PCR b
western blot analysis. Asterisk,
Signiﬁcant increase, compared
to the control group, Hash,
Signiﬁcant decrease, compared
to the control group
Fig. 2 The effects of Res
(Resveratrol|) 400 mg/kg/day,
Met (Metformin)/250 mg/kg,
Cold and Train (Strength
training) on the plin5 expression
and perilipin 5 protein content in
skeletal muscle. a Real-time
PCR b western blot analysis.
Asterisk, Signiﬁcant increase,
compared to the control group
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Discussion
LD play a major role in the metabolism of tissue lipids, and
plin5 plays an important role in lipolysis of LD, leading to
changes in lipid ﬂux. BAT can interfere with obesity, due to
its important role in thermogenesis. Resveratrol affects the
morphology of LD in rat liver cells, and reduces the
expression of plins family, such as plin2 and TIP47; thus
reduces the triglyceride content of LD and prevents the lipid
accumulation in the liver [17]. The reduction of plin5,
reported in this study, is consistent with the signiﬁcant
reduction of plin5 in BAT in our study. Therefore,
Resveratrol by reducing plin5 in BAT, induce lipolysis in
LD.
Cold is an inducing factor in the browning of adipose
tissue. Cold affects BAT, through the sympathetic nervous
system and beta-3 adrenergic receptor, by activating protein
kinase A, leading to an increase in the factors involved in
the thermogenesis, including UCP-1, PPARβ1, PGC1α, and
PPARα [18]. Jin et al. (2015) showed that cold increases
plin2, after 72 h in BAT, and slightly increases the OXPAT
(PLIN5) after 24 h, and then a slight decrease after 72 h was
reported, while exposing with cold (4 °C) in rats [19]. In the
present study, long-term cold did not alter plin5 in BAT,
which is probably due to the adaptation of rats to cold
temperature.
Strength trainings increase perilipin 5 in BAT, probably
due to the important role that have in the synthesis and
function of mitochondria, as well as lipolysis and lipogen-
esis of LD. In 2016, Ramos et al. showed that strength
trainings (using a treadmill), increased the level of plin5
proteins, in the subclavicular BAT of Sprague rats, relative
to untrained rats, thereby decreasing the amount of acetyl-
coA carboxylase protein in BAT [20]. In the present study,
strength training in BAT only increased the expression of
the plin, but no signiﬁcant change has been found in the
level of plin5 proteins, and this ﬁnding is in contrast with
the study of Ramos et al. This inconsistency is probably due
to the type of animal, used in the study or a consequence of
the design of studies.
Metformin in rats with high-cholesterol diet increases
AMPK by phosphorylation of plin, leading to lipolysis [21].
In our study, Metformin did not produce a signiﬁcant
change in the plin5 protein level in BAT, so it may have led
to lipolysis, by altering the level of plin5 phosphorylation.
The heart is surrounded by lipids from plins family,
especially plin5, acting as a barrier to LD against ATGL and
lipases. The plin5 acts via a PPARα transcription factor,
causing a negative relationship between the levels of intra
myocardial TAG and the cardiac function. Chronic lipid
accumulation also negatively affects the heart function [22].
Myocardial steatosis is associated with coronary heart dis-
eases, so there is an association between increased LD and
heart diseases. Plin5 is an important marker for controlling
lipolysis in the heart, its excessive increase, causes cardiac
steatosis and cardiac hypertrophy [23, 24].
In our study, Resveratrol and strength training have
reduced the plin5 expression, as well as decreased the level
of plin5 protein. Therefore, it is expected to act as a pro-
tective factor, against increased lipids of the heart, by
modulating and increasing the lipolysis, leading to a
decrease in heart triglyceride content.
Plin5 reduces myocardial ischemia by reducing oxidative
stress, and prevents lipolysis of LD. An increase in lipolysis
in rats, lacking plin5, followed by an increase in ROS
(Reactive Oxygen Species), leads to heart malfunction. In
fact, the relative expression of plin5 in the heart is required
for energy storage [25]. According to this study, Metformin
can partly prevent the excessive reduction of plin5. This
function of Metformin is probably due to the sugar burning
Fig. 3 The effects of Res
(Resveratrol|) 400 mg/kg/day,
Met (Metformin)/250 mg/kg,
Cold and Train (Strength
training) on the plin5 expression
and perilipin 5 protein content in
heart muscle. a Real-time PCR b
western blot analysis. Asterisk,
Signiﬁcant increase, compared
to the control group, Hash,
Signiﬁcant decrease, compared
to the control group
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rather than lipid, which is associated with less oxidative
stress.
Strength training increases plin2 and plin5, increasing
intramyocellular triacylglycerol (IMTG), insulin sensitivity,
activity of protein kinase A (PKA), and increasing the
expression of hormone-sensitive lipase. In fat rats with
high-fat diets, increasing intramyocellular lipid (IMCL) also
increases insulin resistance [26].
Plin5 is an important protein in the LD, helping in
turnover of lipids [27]. Cold with increasing PGC1α in
skeletal muscle plays an important role in the synthesis of
mitochondria; plin5 also plays an important role in reg-
ulating PGC1α, therefore, the cold probably affects mito-
chondria by changing the plin5 and PGC1α. Plin5 promotes
the transfer of LD content to mitochondria and optimizes
the oxidation of LD. In addition, plin5 regulates the
hydrolysis of LD, in order to protect the mitochondria
against sudden changes in the density of free fatty acids
[28]. The association between IMCL and sensitivity to
insulin is complex. IMCL increases insulin sensitivity; in
obese people, with increasing IMCL, insulin resistance also
increases; this process has been observed as a paradox in
athletes. Training is associated with an increase in IMCL,
but unlike obese people, increased insulin sensitivity has
also seen in athletes. Increased sensitivity to insulin depends
on the IMCL content [26].
In our study, Resveratrol, Metformin, strength training,
and cold increased the plin5 at the gene and protein levels,
in skeletal muscle. However, the effect of Resveratrol,
especially high-intensity strength training, is more
prominent.
Resveratrol increases SIRT1 protein levels in skeletal
muscle cells [29]. SIRT1 as a deacetylase controls PGC-1α
gene expression [30] and SIRT1/ PGC-1α pathway can
directly regulate the biophysiological functions of skeletal
muscle. On the other hand, during stimulation of cells or
tissues by exercise and cold exposure, plin5 is phosphory-
lated by protein kinase A and activates SIRT1/ PGC-1α
pathway [31]
We anticipate that the observed changes in this study in
all four groups’ lead to higher IMTG production and more
lipid accumulation in the skeletal muscle, followed by
increased insulin sensitivity.
Conclusion
Plin5 is important because of the unique properties and
different roles that it plays in BAT, skeletal, and cardiac
muscle. Resveratrol reduces plin5 in BAT, accelerating the
lipid hydrolysis in BAT. Therefore, it likely leads to a
weight loss. In heart, Resveratrol and strength training
reduce plin5 and can therefore lead to a decrease in
myocardial steatosis. In skeletal muscle, Resveratrol,
strength training, cold, and Metformin have been shown to
increase plin5. An increase in perilipin-5 in the skeletal
muscle may reduce insulin resistance.
The ﬁndings of this study help to understand the features
and implications of plin5 in various tissues and the impor-
tant role of this protein in obesity-related diseases.
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